The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Comparison of modern and conventional imaging techniques in establishing multiple myeloma‐related bone disease: a systematic review
Abstract
Summary: This systematic review of studies compared magnetic resonance imaging ( MRI ), 18 F ‐fluorodeoxyglucose positron emission tomography ( FDG ‐ PET ), FDG ‐ PET with computerized tomography ( PET ‐ CT ) and CT with whole body X‐Ray ( WBXR ) or (whole body) CT in order to provide evidence‐based diagnostic guidelines in multiple myeloma bone disease. A comprehensive search of 3 bibliographic databases was performed; methodological quality was assessed using Q uality A ssessment of D iagnostic A ccuracy S tudies ( QUADAS ) criteria (score 1–14). Data from 32 directly comparative studies were extracted. The mean QUADAS score was 7·1 (3–11), with quality hampered mainly by a poor description of selection and execution criteria. All index tests had a higher detection rate when compared to WBXR , with up to 80% more lesions detected by the newer imaging techniques; MRI (1·12–1·82) CT (1·04–1·33), PET (1·00–1·58) and PET ‐ CT (1·27–1·45). However, the modern imaging techniques detected fewer lesions in the skull and ribs. In a direct comparison CT and MRI performed equally with respect to detection rate and sensitivity . This systematic review supports the I nternational M yeloma W orking G roup guidelines, which recommend that WBCT can replace WBXR . In our opinion, the equal performance of MRI also indicates that it is a valuable alternative. As lesions of the skull and ribs are underdiagnosed by modern imaging techniques we advise additional X ‐rays of these regions. The consequences of this approach are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Whiting, P., Rutjes, A. W., Reitsma, J. B., Bossuyt, P. M., & Kleijnen, J. (2003) · BMC Medical Research Methodology · doi:10.1186/1471-2288-3-25 · Cited by 3,592
Cited by
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
Rajkumar, S. V., Dimopoulos, M. A., Palumbo, A., Blade, J., Merlini, G., Mateos, M.-V., Kumar, S., Hillengass, J., Kastritis, E., Richardson, P., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70442-5 · Cited by 4,978
Self-citationEuropean Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications
Terpos, E., Kleber, M., Engelhardt, M., Zweegman, S., Gay, F., Kastritis, E., van de Donk, N. W. C. J., Bruno, B., Sezer, O., Broijl, A., et al. (2015) · Haematologica · doi:10.3324/haematol.2014.117176 · Cited by 988
Self-citationMultiple Myeloma: Diagnosis and Treatment
Rajkumar, S. V., & Kumar, S. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.11.007 · Cited by 812
Cavo, M., Terpos, E., Nanni, C., Moreau, P., Lentzsch, S., Zweegman, S., Hillengass, J., Engelhardt, M., Usmani, S. Z., Vesole, D. H., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30189-4 · Cited by 544
Self-citationMultiple myeloma: 2016 update on diagnosis, risk‐stratification, and management
Rajkumar, S. V. (2016) · American Journal of Hematology · doi:10.1002/ajh.24402 · Cited by 456
Metadata
- Authors
- Regelink, J. C., Minnema, M. C., Terpos, E., Kamphuis, M. H., Raijmakers, P. G., Pieters – van den Bos, I. C., Heggelman, B. G. F., Nievelstein, R., Otten, R. H. J., van Lammeren – Venema, D., Zijlstra, J. M., Arens, A. I. J., de Rooy, J. W., Hoekstra, O. S., Raymakers, R., Sonneveld, P., Ostelo, R. W., & Zweegman, S.
- Venue
- British Journal of Haematology
- Publisher
- Wiley
- Published
- 2013-04-25
- Volume
- 162
- Issue
- 1
- Pages
- 50-61
- ISSN
- 0007-1048 (ISSN-L)
- 1365-2141
- OpenAlex
- W2145941728
- Cited by
- 211
- References
- 1
- FWCI
- 2.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.